Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly targeting cancer-related proteins. Its structure allows for selective modification, making it valuable in developing compounds with high binding affinity to specific enzyme sites. Also explored in the design of novel antiviral agents due to its ability to mimic purine bases in nucleotide analogs. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies to optimize drug candidates.